Galapagos | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AstraZeneca USD 388M 0 2024-12
Biogen USD 100K 0 2024-12
Genmab DKK 66M 0 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
GRIFOLS EUR 119.6M 0 2024-12
Hikma Pharmaceutical USD 40M 0 2024-06
Incyte USD 193K 1000 2024-12
Merck EUR 168M 397M 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Roche Holding CHF 107M 0 2024-06
UCB EUR 189.72 584M 2024-06
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Galapagos Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.